-
Je něco špatně v tomto záznamu ?
Měření tělesného tuku u chronického onemocnění ledvin - význam pro výzkum a klinickou praxi
[Body fat measurement in chronic kidney disease: implications in research and clinical practice]
Tetsuo Shoji, Eiji Ishimura, Joshiki Nishizawa
Jazyk čeština Země Česko
- MeSH
- antropometrie MeSH
- chronické selhání ledvin mortalita patologie MeSH
- lidé MeSH
- míra přežití MeSH
- prediktivní hodnota testů MeSH
- tuková tkáň MeSH
- vyšetření funkce ledvin MeSH
- Check Tag
- lidé MeSH
The paradoxical and inverse association between body mass index and mortality risk in patients with end-stage renal disease has raised a question of whether an increased fat mass is good or bad for patients with chronic kidney disease. The purpose of this review is to update the concept on body fat in patients with chronic kidney disease. RECENT FINDINGS: A greater fat mass is an independent predictor of better survival in patients on maintenance hemodialysis. Following the initiation of dialysis, chronic kidney disease patients gain body weight due mainly to increased fat mass. Fat mass gain over time predicts better survival in hemodialysis patients. In predialysis chronic kidney disease, there is also an inverse association between body mass index and mortality risk. The metabolic syndrome and a high body mass index are independent predictors for development of chronic kidney disease and end-stage renal disease, respectively. In diabetic patients with chronic kidney disease, however, a high initial body mass index is associated with a slower decline in glomerular filtration rate. SUMMARY: The impacts of fat mass on survival and renal function appear to vary depending upon the absence or presence, and stages of chronic kidney disease. Further research is required for optimal nutritional management and improved outcomes of patients with chronic kidney disease.
Body fat measurement in chronic kidney disease: implications in research and clinical practice
Lit.: 25
- 000
- 03097naa 2200397 a 4500
- 001
- bmc07506330
- 003
- CZ-PrNML
- 005
- 20111210122557.0
- 008
- 080707s2008 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Shoji, Tetsuo
- 245 10
- $a Měření tělesného tuku u chronického onemocnění ledvin - význam pro výzkum a klinickou praxi / $c Tetsuo Shoji, Eiji Ishimura, Joshiki Nishizawa
- 246 11
- $a Body fat measurement in chronic kidney disease: implications in research and clinical practice
- 314 __
- $a Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka
- 504 __
- $a Lit.: 25
- 520 9_
- $a The paradoxical and inverse association between body mass index and mortality risk in patients with end-stage renal disease has raised a question of whether an increased fat mass is good or bad for patients with chronic kidney disease. The purpose of this review is to update the concept on body fat in patients with chronic kidney disease. RECENT FINDINGS: A greater fat mass is an independent predictor of better survival in patients on maintenance hemodialysis. Following the initiation of dialysis, chronic kidney disease patients gain body weight due mainly to increased fat mass. Fat mass gain over time predicts better survival in hemodialysis patients. In predialysis chronic kidney disease, there is also an inverse association between body mass index and mortality risk. The metabolic syndrome and a high body mass index are independent predictors for development of chronic kidney disease and end-stage renal disease, respectively. In diabetic patients with chronic kidney disease, however, a high initial body mass index is associated with a slower decline in glomerular filtration rate. SUMMARY: The impacts of fat mass on survival and renal function appear to vary depending upon the absence or presence, and stages of chronic kidney disease. Further research is required for optimal nutritional management and improved outcomes of patients with chronic kidney disease.
- 650 _2
- $a tuková tkáň $7 D000273
- 650 _2
- $a antropometrie $7 D000886
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chronické selhání ledvin $x mortalita $x patologie $7 D007676
- 650 _2
- $a vyšetření funkce ledvin $7 D007677
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a míra přežití $7 D015996
- 700 1_
- $a Ishimura, Eiji
- 700 1_
- $a Nishizawa, Joshiki
- 773 0_
- $w MED00156014 $t Current opinion in nephrology and hypertension $g Roč. 2, č. 1 (2008), s. 14-18 $x 1802-3827
- 910 __
- $a ABA008 $b B 2490 $c 903 $y 1
- 990 __
- $a 20080707091702 $b ABA008
- 991 __
- $a 20080708084557 $b ABA008
- 999 __
- $a ok $b bmc $g 621955 $s 474388
- BAS __
- $a 3
- BMC __
- $a 2008 $b 2 $c 1 $d 14-18 $i 1802-3827 $m Current Opinion in Nephrology and Hypertension (České vyd.) $x MED00156014
- LZP __
- $a 2008-7/mkme